References
[+]
Anton R, Schacht J, Voronin K, et al. Aripiprazole Suppression of Drinking in a Clinical Laboratory Paradigm: Influence of Impulsivity and Self-Control. Alcohol Clin Exp Res 2017; 41: 1370-80.
Coffin P, Santos G, Das M, et al. Aripiprazole for the treatment of methamphetamine dependence: a randomized, double-blind, placebo-controlled trial. Addiction 2013; 108: 751-61.
Kranzler HR, Covault J, Pierucci-Lagha A et al. Effects of aripiprazole on subjective and physiological responses to alcohol. Alcohol Clin Exp Res 2008; 32: 573-9.
Lexi-Comp ONLINE, Lexi-Comp ONLINE Interaction Analysis, Hudson, Ohio: Lexi-Comp, Inc.; 2021; July 20, 2021.
Lofwall M, Nuzzo P, Campbell C, et al. Aripiprazole effects on self-administration and pharmacodynamics of intravenous cocaine and cigarette smoking in humans. Exp Clin Psychopharmacol 2014; 22: 238-47.
Párraga H, Sherman B. Acute Dystonia After Stimulant Discontinuation in 2 ADHD Children Receiving Aripiprazole. J Clin Psychopharmacol 2015; 35: 480-1.
Potvin S, Pampoulova T, Mancini-Marie T et al. Increased extrapyramidal symptoms in patients with schizophrenia and a comorbid substance use disorder. J Neurol Neurosurg Psychiatry 2006; 77: 796-8.
Stoops W, Bennett J, Lile J, et al. Influence of aripiprazole pretreatment on the reinforcing effects of methamphetamine in humans. Prog Neuropsychopharmacol Biol Psychiatry 2013; 47: 111-7.
Vollenweider FX, Vollenweider-Scherpenhyzen MFI, Babler A et al. Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. Neuroreport 1998; 9: 3897-902.
Voronin K, Randall P, Myrick H et al. Aripiprazole effects on alcohol consumption and subjective reports in a clinical laboratory paradigm--possible influence of self-control. Alcohol Clin Exp Res 2008; 32: 1954-61.
Yoshimi N, Fujita Y, Ohgi Y, et al. Effects of brexpiprazole, a novel serotonin-dopamine activity modulator, on phencyclidine-induced cognitive deficits in mice: A role for serotonin 5-HT1A receptors. Pharmacol Biochem Behav 2014; 124: 245-9.
Zuccoli ML, Muscella A, Fucile C et al. Paliperidone for the treatment of ketamine-induced psychosis: a case report. Int J Psychiatry Med 2014; 48: 103-8.